Narrative review summarizes interleukin-mediated macrophage polarization and its role in atopic dermatitis, highlighting diagnostic potential and therapeutic insights.
Atopic dermatitis (AD) is a chronic inflammatory skin disease driven by immune dysregulation and skin barrier impairment. As a core regulatory axis, interleukin-mediated macrophage polarization modulates the inflammatory cascade and barrier repair via NF-κB/STAT6/NLRP3 pathway crosstalk. This narrative review systematically summarizes the bidirectional regulatory mechanism of the interleukin-macrophage polarization axis in AD, clarifies the vicious cycle linking immune imbalance, inflammatory amplification and barrier damage, and updates targeted interventions including biological agents and natural products. We further analyze the translational challenges of this axis and propose future directions for precise stratified therapy. This review innovatively integrates the immune-barrier crosstalk mechanism and translational insights, providing a theoretical basis for pathogenesis-oriented precise treatment of refractory AD.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: